Stock Rich List
#33 on the rich list of 14,644 insiders

Robert W. Duggan

Co-Chief Executive Officer at Summit Therapeutics; Director at Pulse Biosciences. Based in Miami, Florida.

$8.59B
in disclosed stock, +$104.0M (+1.23%) today
Live prices, last trade 2:33 PM ET
Rank
33rd of 14,644
Companies held
2
Largest holding
SMMT, 73.8% of total
Latest SEC filing
Nov 16, 2026
Listed but not counted
$5.7M

What the $8.59B is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Summit Therapeutics SMMT
Common Stock
Directly573,883,879$10.71$6.15B71.6%Form 4, Nov 16, 2026
Pulse Biosciences PLSE
Common Stock
Directly48,370,047$45.42$2.20B25.6%Form 4/A, May 11, 2026
Summit Therapeutics SMMT
Common Stock
Through the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee
Reported jointly by 2 insiders; split evenly
12,912,237$10.71$138M1.6%Form 4, Nov 16, 2026
Summit Therapeutics SMMT
Common Stock
Through the Shaun Zanganeh Irrevocable Trust, with the Spouse of Reporting Person as Trustee
Reported jointly by 2 insiders; split evenly
5,099,888$10.71$54.6M0.6%Form 4, Nov 16, 2026
Pulse Biosciences PLSE
Common Stock
Affiliated Company 1630,109$45.42$28.6M0.3%Form 4/A, May 11, 2026
Pulse Biosciences PLSE
Common Stock
Affiliated Company 2450,189$45.42$20.4M0.2%Form 4/A, May 11, 2026
Summit Therapeutics SMMT
Common Stock
Immediate family member of Spouse76,680$10.71$821K0.0%Form 4, Nov 16, 2026

Share counts are the amounts Robert W. Duggan reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Robert W. Duggan's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Summit Therapeutics SMMT
Common Stock
Through Spouse
Counted on the profile of the insider who holds these shares directly
531,000$10.71$5.7M—Form 4, Nov 16, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jun 12, 2026BoughtSMMT3,810,000$13.12$50.0MView
Jun 4, 2026BoughtSMMT100,000$14.60$1.5MView
May 11, 2026BoughtPLSE660,233$19.69$13.0MView
May 11, 2026BoughtPLSE660,233$19.69$13.0MView
Oct 21, 2025BoughtSMMT26,680$18.74$500KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
30Patricia F. Elcan
10% owner, HCA Healthcare. Nashville, TN
$9.29B−$282.1M (−2.95%)
31Thomas F. Frist III
Director, HCA Healthcare. Nashville, TN
$9.21B−$279.6M (−2.95%)
32Alexander C. Karp
See Remarks, Palantir Technologies. Aventura, FL
$9.17B−$65.7M (−0.71%)
33Robert W. Duggan
Co-Chief Executive Officer, Summit Therapeutics. Miami, FL
$8.59B+$104.0M (+1.23%)
34Matthew Prince
CEO & Board Co-Chair, Cloudflare. Austin, TX
$8.56B+$83.1M (+0.98%)
35Jagtar Singh Chaudhry
CEO & Chairman, Zscaler. San Jose, CA
$8.27B+$336.5M (+4.24%)
36George B. Kaiser
Director, BOK Financial. Tulsa, OK
$7.86B−$156.1M (−1.95%)

Other Summit Therapeutics insiders

All SMMT insiders

Questions

How much stock does Robert W. Duggan own?

Robert W. Duggan holds $8,586,062,116 in listed stock based on SEC filings and current prices, mostly Summit Therapeutics (SMMT). That ranks 33rd on the Stock Rich List.

Is this Robert W. Duggan's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Robert W. Duggan last buy or sell stock?

The most recent open-market trade on file is a purchase of 3,810,000 SMMT shares on Jun 12, 2026 at $13.12.